Kao Corp. Stock
€17.82
Your prediction
Kao Corp. Stock
Pros and Cons of Kao Corp. in the next few years
Pros
Cons
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | 0.730% | -50.000% | -45.186% | -52.531% | -48.001% | -47.043% | -66.704% |
| Unicharm Corp. | -3.690% | -1.386% | -2.353% | - | 2.469% | - | - |
| Pola Orbis Holdings Inc. | 1.460% | 2.963% | 4.511% | -5.442% | 0.000% | -46.947% | -68.409% |
| Kose Corp | 4.290% | 7.353% | 2.817% | -14.620% | 4.286% | -67.556% | -78.045% |
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4


